This inventor holds 1 USPTO granted patent. Top assignee: Serum Institute of India Private Limited. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Hitesh Kumar Malviya: Innovator in Vaccine Formulation
Introduction
Hitesh Kumar Malviya is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of vaccine formulation, particularly in the development of stable multivalent pneumococcal polysaccharide-protein conjugate vaccines. His innovative methods aim to enhance the efficacy and stability of vaccine formulations.
Latest Patents
Hitesh Kumar Malviya holds a patent titled "Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof." This invention provides methods for the preparation of stable multivalent pneumococcal polysaccharide-protein conjugate vaccine formulations. The patent outlines techniques to achieve optimal percent adsorption for each conjugate, preventing aggregation through various means, including the use of a histidine-succinic acid buffer system and specific polysaccharide to protein ratios. He has 1 patent to his name.
Career Highlights
Hitesh Kumar Malviya is currently associated with the Serum Institute of India Private Limited, a leading organization in the field of vaccine production. His work focuses on improving vaccine formulations, which is crucial for public health.
Collaborations
He has collaborated with notable colleagues such as Rajeev Mhalasakant Dhere and Swapan Kumar Jana, contributing to advancements in vaccine technology.
Conclusion
Hitesh Kumar Malviya's innovative work in vaccine formulation exemplifies the importance of research and development in healthcare. His contributions are vital for enhancing vaccine efficacy and stability, ultimately benefiting public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile